Archive for June 2026
Why GLP-1 Users Move Less (And How to Stay Active on Any GLP-1)
If you’re on GLP-1 medications, you’ve probably noticed something strange. You’re eating less. You’re losing weight rapidly. Everything seems to be working perfectly. But you’re also moving less. And new research presented at ENDO 2026 (Endocrine Society Annual Meeting) just confirmed what many people have been experiencing: GLP-1 users significantly reduce their daily activity levels…
Click Here to Read MoreGLP-1 Fiber Intake: Why 30-40g Daily Is Essential (70% Are Deficient)
If you’re taking Ozempic, Wegovy, Mounjaro, Zepbound, or Foundayo, you’re probably dealing with a problem that most doctors won’t adequately address. Constipation. Research shows that approximately 70% of GLP-1 users experience severe constipation. But here’s what’s critical to understand: this isn’t inevitable. It’s not a permanent side effect of the medication. It’s the result of…
Click Here to Read MoreGLP-1 Personality Changes: Real Or Myth?
Do GLP-1 Medications Change Your Personality? The Science Behind Dopamine, Food Reward, and Social Behavior If you’ve been taking Ozempic, Wegovy, Mounjaro, or Zepbound for several weeks or months, you may have noticed something unexpected: food simply doesn’t excite you anymore. Many people describe losing interest in restaurant outings, family dinners, happy hours, and even…
Click Here to Read MoreHow To Lose Fat And Not Muscle On GLP-1 Medications
The Exact 5-Component Protocol (Ozempic, Wegovy, Mounjaro, Zepbound, Foundayo) Evidence-Based Guide to Preserving Metabolism While Losing Weight The Muscle Loss Crisis Nobody’s Talking About If you’re on Ozempic, Wegovy, Mounjaro, Zepbound, or the newly FDA-approved Foundayo, your doctor probably told you about nausea and constipation. What they likely didn’t mention? Up to 40% of the…
Click Here to Read More